Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

negligenceliabilitystrict liabilitycommon law
negligenceliabilitystrict liability

Related Cases

Geiger v. Simpson Methodist-Episcopal Church of Minneapolis, 174 Minn. 389, 219 N.W. 463, 62 A.L.R. 716
View Case »
Hope v. Pelzer, 536 U.S. 730, 122 S.Ct. 2508, 153 L.Ed.2d 666, 70 USLW 4710, 02 Cal. Daily Op. Serv. 5768, 2002 Daily Journal D.A.R. 7285, 15 Fla. L. Weekly Fed. S 511
View Case »
Helsel v. Hoosier Ins. Co., 827 N.E.2d 155
View Case »
Sinclair by Sinclair v. Block, 534 Pa. 563, 633 A.2d 1137
View Case »
Gnapinsky v. Goldyn, 23 N.J. 243, 128 A.2d 697
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

Riegel v. Medtronic, Inc., 552 U.S. 312, 128 S.Ct. 999, 169 L.Ed.2d 892, 76 USLW 4087, Prod.Liab.Rep. (CCH) P 17,924, 08 Cal. Daily Op. Serv. 2105, 2008 Daily Journal D.A.R. 2524, 21 Fla. L. Weekly Fed. S 81

Facts

Charles Riegel, a cardiac patient, underwent an angioplasty in 1996 where a Medtronic Evergreen Balloon Catheter was used. The catheter, a Class III medical device, had received FDA premarket approval but was labeled with warnings against its use in patients with certain conditions. During the procedure, the catheter was inflated beyond its rated pressure, leading to its rupture and severe complications for Riegel. Subsequently, Riegel and his wife sued Medtronic, alleging that the catheter was defectively designed and labeled, violating New York common law.

Charles Riegel, a cardiac patient, underwent an angioplasty in 1996 where a Medtronic Evergreen Balloon Catheter was used. The catheter, a Class III medical device, had received FDA premarket approval but was labeled with warnings against its use in patients with certain conditions.

Issue

Whether the Medical Device Amendments of 1976 preempt state-law claims of negligence, strict liability, and implied warranty against manufacturers of medical devices that have received premarket approval from the FDA.

Whether the Medical Device Amendments of 1976 preempt state-law claims of negligence, strict liability, and implied warranty against manufacturers of medical devices that have received premarket approval from the FDA.

Rule

The Medical Device Amendments of 1976 preempt state requirements that are different from or in addition to federal requirements applicable to medical devices, particularly those that relate to safety and effectiveness.

The Medical Device Amendments of 1976 preempt state requirements that are different from or in addition to federal requirements applicable to medical devices, particularly those that relate to safety and effectiveness.

Analysis

The Court analyzed the preemption clause of the Medical Device Amendments, determining that the FDA's premarket approval process established specific federal requirements for the Medtronic catheter. The Court concluded that the Riegels' common-law claims imposed state requirements that were different from the federal standards, thus falling under the preemption clause. The Court emphasized that allowing state claims would disrupt the federal regulatory scheme designed to ensure the safety and effectiveness of medical devices.

The Court analyzed the preemption clause of the Medical Device Amendments, determining that the FDA's premarket approval process established specific federal requirements for the Medtronic catheter.

Conclusion

The Supreme Court affirmed the lower court's ruling, holding that the Riegels' state-law claims were preempted by the federal requirements established under the Medical Device Amendments.

The Supreme Court affirmed the lower court's ruling, holding that the Riegels' state-law claims were preempted by the federal requirements established under the Medical Device Amendments.

Who won?

Medtronic prevailed in the case because the Supreme Court found that the federal preemption clause barred the Riegels' state-law claims, which would impose additional requirements on the manufacturer beyond those mandated by federal law.

Medtronic prevailed in the case because the Supreme Court found that the federal preemption clause barred the Riegels' state-law claims, which would impose additional requirements on the manufacturer beyond those mandated by federal law.

You must be